Clinical trial
A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Subjects With Knee Osteoarthritis
NCT00704847 is registered in ClinicalTrials.gov with Nordic Bioscience A/S as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Multi-Center, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Salmon Calcitonin in the Treatment of Subjects With Knee Osteoarthritis
- Lead sponsor
- Nordic Bioscience A/S
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- June 30, 2008
- Completion date
- June 30, 2011
- Enrollment
- 1,030 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.